Skip to main
BDX

BDX Stock Forecast & Price Target

BDX Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 31%
Buy 15%
Hold 54%
Sell 0%
Strong Sell 0%

Bulls say

Becton Dickinson is taking proactive steps to improve its financials through share repurchases and debt paydown, and its prospects for growth are solid with positive results in its first quarter and a focus on efficiency. While there are risks and potential challenges, BD remains committed to its growth and shareholder returns through its capital allocation plan. On a financial level, BD has a strong pipeline for acquisitions and is well-positioned in high-growth markets, with international revenue accounting for 43% of its business.

Bears say

Becton Dickinson is a global leader in the medical technology industry, with a diverse portfolio of products aimed at improving healthcare delivery. However, their recent spinoff of their Biosciences and Diagnostic Solutions business combined with ongoing headwinds may impact their growth trajectory. Additionally, competition and changes in healthcare delivery could pose risks to their business.

BDX has been analyzed by 13 analysts, with a consensus rating of Buy. 31% of analysts recommend a Strong Buy, 15% recommend Buy, 54% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Becton, Dickinson and Co. and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Becton, Dickinson and Co. (BDX) Forecast

Analysts have given BDX a Buy based on their latest research and market trends.

According to 13 analysts, BDX has a Buy consensus rating as of May 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $184.23, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $184.23, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Becton, Dickinson and Co. (BDX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.